EFFICACY OF TRANSUMBILICAL SINGLE-PORT LAPAROSCOPIC OVARIAN CYSTECTOMY IN TREATING LARGE BENIGN OVARIAN CYSTS IN FEMALE ATHLETES

Abstract

Objective: This study investigates the efficacy and safety of transumbilical single-port laparoscopic ovarian cystectomy for managing large benign ovarian cysts in female athletes, aiming to minimize recovery time and optimize postoperative outcomes conducive to athletic performance. Methods: Conducted from January to December 2023, this Chinese study focused on female athletes diagnosed with large benign ovarian cysts, utilizing ultrasound, CT/MRI imaging, and CA-125 markers for preoperative assessment. A homemade single-port device was used to facilitate minimal scarring. The technique involved a small incision around the navel for cyst extraction, emphasizing minimal blood spillage and optimal preservation of ovarian function crucial for the athletes' physical health. Results: Comparative analysis between single-port and multi-port techniques showed no significant differences in the surgical outcomes of cystectomies. Data indicated similar distributions of unilateral and bilateral cystectomies and pathologic features across both techniques. Complications were slightly varied but statistically non-significant. Key surgical metrics such as operative time, blood loss, hospital stay, and incidence of pelvic adhesions were comparable, emphasizing the minimal impact technique's efficacy. Conclusion: Transumbilical single-port laparoscopic surgery is a viable and effective alternative to traditional multi-port approaches for the removal of large benign ovarian cysts, particularly for female athletes. This method offers equivalent surgical outcomes with the added benefits of reduced scarring and potentially quicker recovery, crucial for the swift return to training and competition. Such attributes make it a preferred choice in sports medicine for managing ovarian cysts in athletes, ensuring minimal interruption to their training regimens and performance.